Eris Lifesciences has reported results for first quarter ended June 30, 2017.
The company has reported 12.51% jump in its net profit at Rs 69.95 crore for the quarter under review as compared to Rs 62.17 crore for the same quarter in the previous year. However, the total income of the company decreased by 10.67% at Rs 169.35 crore for Q1FY18 as compared Rs 189.57 crore for the corresponding quarter previous year.
On consolidate basis, the company has reported 13.45% rise in its net profit at Rs 70.84 crore for the quarter ended June 30, 2017 as compared to Rs 62.44 crore for the corresponding quarter in the FY17. Total consolidated income of the company increased marginally by 2.39% at Rs 192.07 crore for quarter under review as compared to Rs 187.58 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1531.05 |
Dr. Reddys Lab | 5790.00 |
Cipla | 1408.65 |
Zydus Lifesciences | 1114.70 |
Lupin | 1629.50 |
View more.. |